Saturday, Sep 23, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Business | Sapala Organics To Set Up New Unit In Hyderabad

Sapala Organics to set up new unit in Hyderabad

Sapala Organics is setting up a state-of-the-art manufacturing facility near Keesara for producing high-value compounds

By Y V Phani Raj
Published Date - 12:05 AM, Fri - 23 July 21
Sapala Organics to set up new unit in Hyderabad
Sapala has the expertise in synthesising several nucleosides and organic compounds used in diagnostic and therapeutic applications.
whatsapp facebook twitter telegram

Hyderabad: Hyderabad-based Sapala Organics, specialised in custom synthesis, is setting up a state-of-the-art manufacturing facility near Keesara for producing high-value compounds and oligonucleotides to meet additional capacity requirements.

Sapala Organics president and CEO Dr PY Reddy told Telangana Today, “We have procured about 6.5 acres at Keesara for this facility, and in the first phase, we may invest about Rs 60 crore. Groundbreaking may happen in August, and we expect the plant to be fully commissioned in 18 months (by early 2023).”

The company which is involved in a range of activities such as custom synthesis, bulk outsourcing, analytical and technical services, process development and kilo-scale contract manufacturing, currently operates out of its facility at IDA Mallapur, Phase II, Hyderabad.

mRNA vaccine material

In a major boost to its efforts, Sapala, along with its Japanese partner, has entered into a supply agreement with a global contract manufacturing organisation (CMO) from the US for the supply of unnatural nucleoside-Pseudouridine (Ψ) and N1-Methyl-Pseudouridne (1-Me-Ψ) and cap reagents used in mRNA vaccine development. Nucleosides are a subunit of nucleic acids.

The CMO uses the 1-Me-Ψ to mimic the natural uridine (nucleoside) to affect the coding specificity and to create a mutation to promote suppression of the active virus in the body. The cap reagents are used in the mRNA vaccine development to produce the most active, longest lasting and least toxic mRNA.

Reddy said Sapala has the expertise in synthesising several nucleosides and organic compounds used in diagnostic and therapeutic applications. The company has developed technology for the scale of deoxynucleoside triphosphates (dNTPs) used for the synthesis of probes and primers for diagnostic kits to detect Covid-19 and other viruses. The company also developed scale-up technology for lipid nanoparticles such as N-Acetylgalactosamine (GalNAc) compounds used for delivery of the oligonucleotides into the cells.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .

Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • mRNA vaccine development
  • oligonucleotides
  • Sapala Organics
  • Sapala Organics president and CEO Dr PY Reddy

Related News

    Latest News

    • Hyderabad: Two buildings at Mindspace undergoes swift demolition for major redevelopment

      4 mins ago
    • Taiwan factory fire leaves at least 5 dead, more than 100 injured

      4 mins ago
    • Google mocks Apple in new video for lack of RCS messaging support

      14 mins ago
    • Rahul Gandhi travels with student on scooter in Jaipur

      14 mins ago
    • PM Modi lays foundation stone of international cricket stadium in Varanasi

      27 mins ago
    • Saudi Arabia’s economy joins trillion-dollar club: Report

      33 mins ago
    • Hyderabad: St Francis College conducts 43rd Convocation ceremony

      53 mins ago
    • Explainer: What is stapled visa, why has China issued these to athletes from Arunachal Pradesh

      52 mins ago

    company

    • Home
    • About Us
    • Contact Us

    business

    • Subscribe

    telangana today

    • Telangana
    • Hyderabad
    • Latest News
    • Entertainment
    • World
    • Andhra Pradesh
    • Science & Tech
    • Sport

    follow us

    © Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam